ID   NP133
AC   CVCL_UW64
DR   Wikidata; Q98128013
RX   PubMed=3771439;
RX   PubMed=3942687;
RX   PubMed=8120409;
CC   Characteristics: Non-melanogenic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS32 ! HFH-18
SX   Male
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=3771439; DOI=10.1007/BF02623517;
RA   Hu F.-N., Mah K., Teramura D.J.;
RT   "Gossypol effects on cultured normal and malignant melanocytes.";
RL   In Vitro Cell. Dev. Biol. 22:583-588(1986).
//
RX   PubMed=3942687; DOI=10.1111/j.1365-2133.1986.tb02775.x;
RA   Hu F., Mah K., Teramura D.J.;
RT   "Effects of dicarboxylic acids on normal and malignant melanocytes in
RT   culture.";
RL   Br. J. Dermatol. 114:17-26(1986).
//
RX   PubMed=8120409; DOI=10.1111/1523-1747.ep12371782;
RA   Armstrong C.A., Murray N., Kennedy M., Koppula S.V., Tara D.,
RA   Ansel J.C.;
RT   "Melanoma-derived interleukin 6 inhibits in vivo melanoma growth.";
RL   J. Invest. Dermatol. 102:278-284(1994).
//